Lung cancer: open trials in Vietnam

15 open trials have a site in Vietnam. Registry data; only the trial team decides who can take part.

NCT06170788
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Tam Anh General Hospital (Site 4179), Hanoi · National Lung Hospital-Oncology Department (Site 4175), Hanoi · K Hospital - National Cancer Hospital (Site 4174), Hà Nội · Cho Ray Hospital (Site 4171), Ho Chi Minh · Thong Nhat Hospital (Site 4170), Ho Chi Minh City · Ho Chi Minh City Oncology Hospital - Tan Phu Ward (Site 4173), Ho Chi Minh City
Registry updated 2026-11-03
NCT07911449
Osimertinib Plus Stereotactic Radiosurgery/Radiotherapy for EGFR-Mutant Non-Small Cell Lung Cancer With Symptomatic Brain Metastases
Trial Treatment · Phase 2 · Cho Ray Hospital
Cho Ray Hospital - Department of Medical and Radiation Oncology, Oncology Center, Ho Chi Minh City
Registry updated 2026-11-02
NCT06692738
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · AstraZeneca
Can Tho · Hanoi · Ho Chi Minh City · Vinh
Registry updated 2026-10-29
NCT06357533
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Trial Treatment · Phase 3 · AstraZeneca
Da Nang · Hanoi · Hà Nội · Ho Chi Minh City · Huế · Vinh · Vĩnh Yên
Registry updated 2026-10-28
NCT06627647
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
Trial Treatment · Phase 3 · AstraZeneca
Can Tho · Hanoi · Ho Chi Minh City · Vinh
Registry updated 2026-10-28
NCT07472517
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Trial Treatment · Phase 3 · Boehringer Ingelheim
Hanoi Oncology Hospital, Hanoi · Vietnam National Cancer Hospital, Hanoi · University Medical Center HCMC, Ho Chi Minh City · Ho Chi Minh Oncology Hospital, Ho Chi Minh City
Registry updated 2026-10-28
NCT07808164
ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort
Research · Tam Anh Research Institute
Tam Anh General Hospital, Hanoi · Tam Anh TP. Ho Chi Minh Hospital, Ho Chi Minh City
Registry updated 2026-10-26
NCT07291037
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Trial Treatment · Phase 3 · AstraZeneca
Hanoi · Ho Chi Minh City · Vinh
Registry updated 2026-10-13
NCT07396558
Intermittent Erector Spinae Plane Block Via Subcutaneous Port for Cancer Pain
Trial Treatment · Hanoi Medical University
Hanoi Medical University, Hanoi
Registry updated 2026-09-17
NCT07234929
Effectiveness of Chat-based Mobile Application for Consultation (Zalo) in Improving Compliance With Follow-up Tests After Abnormal Chest X-ray Findings Interpret by Artificial Intelligent
Trial Treatment · Gia Dinh People Hospital
Nhan Dan Gia Dinh Hospital, Ho Chi Minh City
Registry updated 2026-09-16
NCT06350097
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Trial Treatment · Phase 3 · AstraZeneca
Hanoi · Hà Nội · Ho Chi Minh City · Vinh
Registry updated 2026-08-26
NCT06227728
Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.
Research · Gene Solutions
University of Medicine and Pharmacy at HCMC, Ho Chi Minh City · Medical Genetics Institute, Ho Chi Minh City
Registry updated 2026-01-16
NCT07126626
Validation of the SPOT-MAS Lung Test Using Circulating Tumor DNA for the Detection of Lung Cancer
Research · Gene Solutions
Medical Genetics Institute, Ho Chi Minh City
Registry updated 2025-08-17
NCT06167460
Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.
Research · Gene Solutions
Medical Genetics Institute, Ho Chi Minh City
Registry updated 2025-07-16
NCT06391749
Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
Research · Gene Solutions
Medical Genetics Institute, Ho Chi Minh City
Registry updated 2025-07-16

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error